John F. Crowley - Jan 2, 2024 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Role
Executive Chairman, Director
Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Jan 2, 2024
Transactions value $
-$1,466,882
Form type
4
Date filed
1/4/2024, 06:33 PM
Previous filing
Dec 19, 2023
Next filing
Jan 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award $0 +145K +15.85% $0.00 1.06M Jan 2, 2024 Direct F1
transaction FOLD Common Stock Tax liability -$1.47M -108K -10.26% $13.53 949K Jan 3, 2024 Direct
holding FOLD Common Stock 64.9K Jan 2, 2024 By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +250K $0.00 250K Jan 2, 2024 Common Stock 250K $14.24 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in full on the one year anniversary of the grant date and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
F2 One hundred percent of the shares subject to this option will vest and become exercisable on the one year anniversary of the date of grant.

Remarks:

The above grants were made pursuant to the employment contract between Mr. Crowley and Amicus, dated August 1, 2022.